Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher

‘We have a buy on Dr Reddy’s and Lupin. Dr Reddy’s definitely has a positive but the valuation remains very challenging after this recent run up of Rs 1,000 or more.’